uniQure
uniQure cuts staff and R&D projects to extend gene therapy cash runway
Anika Sharma
uniQure, a biotech company focused on gene therapy, is implementing a significant workforce reduction as part of a strategic restructuring ...
Despite CSL’s hemophilia B gene therapy, NICE is not persuaded
SG Tylor
The UK’s National Institute for Health and Care Excellence (NICE) has expressed hesitation in recommending approval for CSL Behring and ...
uniQure craters on the gene therapy data from Huntington Disease
SG Tylor
Source –uniQure On June 21, 2023 uniQure announced promising interim data, including up to 24 months of follow-up, from 26 ...
